The Multi-disciplinary Treatment of Functional Gut Disorders Study
NCT03078634 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 188
Last updated 2023-11-29
Summary
Randomised controlled trial comparing standard outpatient clinic treatment with multi-disciplinary clinic treatment for functional gastrointestinal disorders. Patients will be followed up to end of clinic treatment and 12 months beyond the end of treatment. Symptoms, quality of life, costs to the healthcare system and psychological outcomes will be assessed.
Conditions
- Irritable Bowel Syndrome
- Functional Dyspepsia
- Constipation - Functional
- Faecal Incontinence
- Functional Abdominal Pain Syndrome
- Other Rome IV Functional Gastrointestinal Disorders
Interventions
- OTHER
-
Multi-disciplinary clinic model
Clinic model incorporating multiple disciplines for the treatment of functional gut disorders. Disciplines include: gastroenterologists, psychiatrists, psychologists, hypnotherapists, behavioural therapists and dieticians. End of clinic case conference involving clinical disciplines will also occur to coordinate care.
- OTHER
-
Standard outpatient care
Standard care provided in outpatient clinics staffed by GI doctors only
Sponsors & Collaborators
-
St Vincent's Hospital Melbourne
lead OTHER
Principal Investigators
-
Chamara Basnayake, MBBS · Gastroenterologist / PhD candidate
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-03-16
- Primary Completion
- 2019-02-28
- Completion
- 2020-04-28
Countries
- Australia
Study Locations
More Related Trials
-
Understanding Mechanisms of Normal and Disordered Defecation
NCT03842007 ·Status: RECRUITING ·Phase: NA
-
Comparative Study on the Efficacy of Vibrabot Capsule and Polyethylene Glycol for Chronic Functional Constipation
NCT06364111 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplant for Autobrewery Syndrome
NCT06083142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Comparison of Efficacy & Tolerability Of PEG 4000 Versus PEG 3350+ Electrolytes for Pediatric Fecal Disimpaction
NCT06349031 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
RCE With FMT in the Treatment of Childhood Constipation
NCT05035784 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Myotomy of the Pylorus To Improve Emptying and Symptoms Trial
NCT05039424 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multi-centre Failed Bowel Prep RCT
NCT02976805 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Gastrografin in the Management of Fecal Impaction in Patients With Severe Chronic Constipation
NCT02784093 ·Status: UNKNOWN ·Phase: PHASE2
-
A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period
NCT01656720 ·Status: COMPLETED ·Phase: PHASE2
-
Studies in Patients With Defecatory Disorders
NCT03317938 ·Status: COMPLETED ·Phase: NA
-
Can Methylnaltrexone Safely Treat Opioid Related Constipation in the Emergency Department?
NCT00949377 ·Status: WITHDRAWN ·Phase: PHASE4
-
Transfer of Healthy Gut Flora for Restoration of Intestinal Microbiota Via Enema for Patients in the Rehabilitative Phase of Malnutrition
NCT03087097 ·Status: TERMINATED ·Phase: PHASE1
-
IQP-PO-101 for the Regulation of Bowel Movement Frequency
NCT01809587 ·Status: COMPLETED ·Phase: PHASE3
-
Fecal Microbiota Transplantation by Oral Capsules for Hepatic Encephalopathy Treatment
NCT06368895 ·Status: RECRUITING ·Phase: PHASE1
-
Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications
NCT00153127 ·Status: COMPLETED ·Phase: PHASE4
-
Real-World Clinical Study on the Efficacy of Vibrating Capsule (Vibrabot Capsule) for Chronic Functional Constipation
NCT06418685 ·Status: NOT_YET_RECRUITING
-
Effect of PEG, Bisacodyl and Prucalopride on Colonic Motility in Healthy Subjects
NCT03279341 ·Status: COMPLETED ·Phase: PHASE4
-
Mode of Action of Moviprep
NCT01622972 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Fecal Microbiota Transplantation for Chronic Intestinal Pseudo-obstruction
NCT02731183 ·Status: COMPLETED ·Phase: NA
-
Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI)
NCT00401375 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Gather Information on the Acceptability of a New Flavor System With Increasing Levels of 2, 4, 6 g or Higher of Mannitol for PEG 3350 in Subjects Having Infrequent Bowel Movements.
NCT04534465 ·Status: COMPLETED ·Phase: PHASE4
-
Bowel Function After Minimally Invasive Urogynecologic Surgery
NCT01044212 ·Status: COMPLETED ·Phase: NA
-
Effect of Fecal Microbiota Transplantation in Slow Transit Constipation
NCT02301221 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®
NCT04759885 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Mosapride on Gut Transit in Patients With Chronic Constipation or Constipated Irritable Bowel Syndrome and Healthy Subjects
NCT02433847 ·Status: UNKNOWN ·Phase: PHASE4